Katz Michael David M.D. 4
4 · Hanover Bancorp, Inc. /NY · Filed Apr 9, 2024
Insider Transaction Report
Form 4
Katz Michael David M.D.
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option
2024-04-09−7,057→ 0 totalExercise: $10.00From: 2017-10-01Exp: 2024-10-01→ Common Stock (7,057 underlying) - Exercise/Conversion
Common Stock
2024-04-09$10.00/sh+7,057$70,570→ 154,279 total
Holdings
- 40(indirect: See Footnote 1)
Common Stock
- 96,760(indirect: See Footnote 2)
Common Stock
- 25(indirect: See Footnote 1)
Common Stock
Footnotes (2)
- [F1]As custodian for reporting person's grandchild
- [F2]Held by a trust to which Dr. Katz is a beneficiary